What is the recommended taper for a patient switching from 40mg propranolol (beta blocker) twice daily (BID) to amlodipine (calcium channel blocker) for hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Switching from Propranolol to Amlodipine: No Taper Required

You can switch directly from propranolol 40 mg BID to amlodipine without any taper, starting amlodipine 5 mg once daily on the same day you stop propranolol. 1, 2

Rationale for Direct Switch

  • Propranolol at 40 mg BID is a low dose (usual angina dosing is 20-80 mg BID per ACC/AHA guidelines), which significantly reduces withdrawal risk 3

  • The patient has uncomplicated hypertension, not post-MI or unstable angina where abrupt beta-blocker cessation poses greater risk 3

  • Research demonstrates that prolonged small-dose propranolol (30 mg daily for 2 weeks) prevents withdrawal syndrome, but your patient is already at a low dose (80 mg total daily), making taper unnecessary 2

  • Amlodipine has a 40-60 hour half-life and takes 6-8 hours to reach peak effect, providing gradual blood pressure control that prevents any rebound hypertension during the transition 1

Specific Switching Protocol

  • Stop propranolol 40 mg BID completely

  • Start amlodipine 5 mg once daily on the same day 1, 4

  • Monitor blood pressure weekly for 3-4 weeks until steady-state is achieved (amlodipine reaches steady-state in 7-10 days) 1, 4

  • Titrate amlodipine to 10 mg once daily if blood pressure remains >140/90 mmHg after 2 weeks 3, 4, 5

When Taper IS Required (Not Your Case)

  • High-dose propranolol (>160 mg daily) in post-MI patients requires taper: reduce to 30 mg daily for 2 weeks before complete discontinuation 2

  • Patients with unstable angina, recent MI (within 3 months), or heart failure: maintain beta-blocker and add amlodipine rather than switching 3

  • Hemodynamically unstable patients or those with severe LV dysfunction: avoid abrupt beta-blocker cessation 3

Critical Monitoring Points

  • Check blood pressure at 1 week, 2 weeks, and 4 weeks post-switch to ensure adequate control and assess need for dose adjustment 1, 4

  • Watch for amlodipine-induced peripheral edema (occurs in first 3 months): if develops, add ACE inhibitor or ARB rather than stopping amlodipine 6

  • Assess for symptoms of beta-blocker withdrawal (tachycardia, tremor, anxiety, rebound hypertension): extremely unlikely at this low dose but monitor heart rate at first visit 2

  • Avoid NSAIDs and other vasodilators that may compound amlodipine's effects 6

Expected Blood Pressure Response

  • Amlodipine 5-10 mg once daily reduces blood pressure by approximately 12-16/10-12 mmHg in mild-to-moderate hypertension 7, 5

  • Blood pressure decreases gradually over 4-8 hours after first dose, with minimal heart rate change due to lack of reflex tachycardia 1

  • If blood pressure remains uncontrolled after 2 weeks on amlodipine 10 mg daily, add a second agent (ACE inhibitor, ARB, or thiazide diuretic) rather than further increasing amlodipine 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Amlodipine-Induced Pedal Edema

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Amlodipine versus atenolol in essential hypertension.

The American journal of cardiology, 1994

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.